Related Experiment Videos
Demystified...recombinant antibodies
K A Smith1, P N Nelson, P Warren
1Division of Cell and Molecular Medicine, Postgraduate Medical Institute, University of Hull, Cottingham Rd, Hull HU6 7RX, UK. k.a.smith@hull.ac.uk
Journal of Clinical Pathology
|August 31, 2004
Summary
Recombinant antibodies, including phage antibodies, are valuable research tools. This article explains their generation and potential clinical applications in diagnostics and therapeutics.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Recombinant antibodies are crucial for biomedical research and clinical applications.
- Humanized antibodies and antibody fragments, such as single chain variable fragments (scFv), are key developments.
- Phage antibody fragments are gaining popularity due to established generation methods.
Purpose of the Study:
- To provide a background on humanized antibodies and antibody fragment generation.
- To explain the methodology and advantages of phage antibody fragments.
- To explore the potential applications of phage antibodies in pathology and clinical settings.
Main Methods:
- Generation of antibody fragments, including single chain Fv fragments.
- Utilizing phage display methodology for affinity enrichment of antibody fragments.
- Affinity enrichment from libraries derived from immune cells.
Main Results:
- Phage antibody fragments can be generated using established affinity enrichment methods.
- Phage display enhances the affinity of existing antibody fragments.
- The article demystifies phage antibodies, highlighting their potential.
Conclusions:
- Phage antibodies offer significant potential as diagnostic and therapeutic reagents.
- Understanding phage antibody technology can drive innovation in clinical settings.
- Biomedical scientists and clinicians should consider the applications of phage antibodies.